AF9 (MLLT3) (K486) Antibody Blocking peptide
AF9 (MLLT3) (K486) Antibody Blocking peptide
Product Specifications
Product Name Alternative
Protein AF-9, ALL1-fused gene from chromosome 9 protein, Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein, YEATS domain-containing protein 3, MLLT3, AF9, YEATS3
UniProt
P42568
Field of Research
Cancer, Epigenetics
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1930198 was selected from the C-term region of human MLLT3 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030182 100 µg
Recombinant HIV-1 (group M, subtype B, isolate BAL) gp120 Protein (His Tag)
Sign In for Pricing
View Details